ssmuБюллетень сибирской медициныBulletin of Siberian Medicine1682-03631819-3684Siberian State Medical University, the Ministry of Healthcare of the Russian Federation10.20538/1682-0363-2008-0-56-63ssmu-3925Research ArticleМАТЕРИАЛЫ IV ВСЕРОССИЙСКОЙ НАУЧНО-ПРАКТИЧЕСКОЙ КОНФЕРЕНЦИИ «ФУНДАМЕНТАЛЬНЫЕ И ПРИКЛАДНЫЕ ИССЛЕДОВАНИЯ В ОНКОГЕМАТОЛОГИИ»Значение конституциональных полиморфизмов гена р53 у больных неходжкинскими злокачественными лимфомамиValue of constitutional polymorphisms gene р53 at patients with non-Hodgkin’s lymphomasПоспеловаТ. И.PospelovaT. I.ВоеводаМ. И.VoyevodaM. I.ВоропаеваЕ. Н.VoropayevaYe. N.БелявскаяВ. А.BelyavskayaV. A.КовыневИ. Б.KovynevI. B.БерезинаО. В.BerezinaO. V.Новосибирский государственный медицинский университетRussian FederationНаучно-исследовательский институт терапии СО РАМНRussian FederationНПО «Вектор», г. НовосибирскRussian Federation20083012200870Приложение 35663Copyright © Поспелова Т.И., Воевода М.И., Воропаева Е.Н., Белявская В.А., Ковынев И.Б., Березина О.В., 20082008Поспелова Т.И., Воевода М.И., Воропаева Е.Н., Белявская В.А., Ковынев И.Б., Березина О.В.Pospelova T.I., Voyevoda M.I., Voropayeva Y.N., Belyavskaya V.A., Kovynev I.B., Berezina O.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://bulletin.ssmu.ru/jour/article/view/3925
.
.
ReferencesВолкова М.А. Клиническая онкогематология: Руководство для врачей/Под ред. М.А. Волковой. 2-е изд., перераб. и доп. М.: Медицина, 2007. 1120 с.Волкова М.А. Клиническая онкогематология: Руководство для врачей/Под ред. М.А. Волковой. 2-е изд., перераб. и доп. М.: Медицина, 2007. 1120 с.Jemal A., Siegal R., Ward E. et al. Cancer Statistics//Cancer Journal for Clinicians. 2006. V. 56. P. 106-130.Jemal A., Siegal R., Ward E. et al. Cancer Statistics//Cancer Journal for Clinicians. 2006. V. 56. P. 106-130.Имянитов Е.Н. Наследственная предрасположенность к онкологическим заболеваниям//Молекул.-биол. технологии в мед. практике. 2007. № 11. С. 12-15.Имянитов Е.Н. Наследственная предрасположенность к онкологическим заболеваниям//Молекул.-биол. технологии в мед. практике. 2007. № 11. С. 12-15.Thiagalingam S.A. Cascade of modules of a network defines cancer progression//Cancer Res. 2006. V. 66 (15). P. 7379-7385.Thiagalingam S.A. Cascade of modules of a network defines cancer progression//Cancer Res. 2006. V. 66 (15). P. 7379-7385.Bunz F., Hwang P.M., Torrance C. et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents//J. Clin. Invest. 1999. V. 104. P. 263-269.Bunz F., Hwang P.M., Torrance C. et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents//J. Clin. Invest. 1999. V. 104. P. 263-269.Nigro J.M., Baker S.J., Preisinger A.C. et al. Mutations in the p53 gene occur in diverse human tumour types//Nature. 1989. V. 342. P. 705-708.Nigro J.M., Baker S.J., Preisinger A.C. et al. Mutations in the p53 gene occur in diverse human tumour types//Nature. 1989. V. 342. P. 705-708.Bellido M., Capello D., Altes A. et al. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement//Haematologica. 2002. V. 87 (9). P. 908-917.Bellido M., Capello D., Altes A. et al. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement//Haematologica. 2002. V. 87 (9). P. 908-917.Scorpa A., Moore P.S., Rigaurd G. et al. Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc//Br. J. Haematol. 1999. V. 107 (1). P. 106-113.Scorpa A., Moore P.S., Rigaurd G. et al. Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc//Br. J. Haematol. 1999. V. 107 (1). P. 106-113.Gaidano G., Volpe G., Pastore C. et al. Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomas//Am. J. Hematol. 1997. V. 56 (4). P. 206-213.Gaidano G., Volpe G., Pastore C. et al. Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomas//Am. J. Hematol. 1997. V. 56 (4). P. 206-213.Bonafe M., Salvioli M., Barbi C. et al. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death//Cell Death. Differ. 2004. V. 11 (9). P. 962-973.Bonafe M., Salvioli M., Barbi C. et al. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death//Cell Death. Differ. 2004. V. 11 (9). P. 962-973.Dumont P., Leu J.I., Della Pietra A.C. et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential//Nat. Genet. 2003. V. 33 (3). P. 357-365.Dumont P., Leu J.I., Della Pietra A.C. et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential//Nat. Genet. 2003. V. 33 (3). P. 357-365.Sallivan A., Syed N., Gasco M. et al. Polymorphism in wildtype p53 modulates response to chemotherapy in vitro and in vivo//Oncogene. 2004. V. 23 (19). P. 3328-3337.Sallivan A., Syed N., Gasco M. et al. Polymorphism in wildtype p53 modulates response to chemotherapy in vitro and in vivo//Oncogene. 2004. V. 23 (19). P. 3328-3337.Lazar V., Hazard F., Bertin F. et al. Simple sequence repeat polymorphism within the p53 gene//Oncogene. 1993. V. 8. P. 1703-1705.Lazar V., Hazard F., Bertin F. et al. Simple sequence repeat polymorphism within the p53 gene//Oncogene. 1993. V. 8. P. 1703-1705.Peller S., Kopilova Y., Slutzki S. et al. A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility//DNA Cell Biol. 1995. V. 14 (12). P. 983-990.Peller S., Kopilova Y., Slutzki S. et al. A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility//DNA Cell Biol. 1995. V. 14 (12). P. 983-990.Ghosh A., Deborah S.D., Matlashewski G. et al. Regulation of Human p53 Activity and Cell Localization by Alternative Splicing//Mol. Cell Biol. 2004. V. 24 (18). P. 7987-7997.Ghosh A., Deborah S.D., Matlashewski G. et al. Regulation of Human p53 Activity and Cell Localization by Alternative Splicing//Mol. Cell Biol. 2004. V. 24 (18). P. 7987-7997.Wu X., Zhao H., Amos C.I. et al. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity//J. Natl. Cancer Inst. 2002. V. 94 (9). P. 681-690.Wu X., Zhao H., Amos C.I. et al. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity//J. Natl. Cancer Inst. 2002. V. 94 (9). P. 681-690.Endoh C., Satoh M., Chin E. et al. Aberrations of the p53 gene in roentgenographically occult squamous cell carcinoma of the ung//Kyobu Geka. 1996. V. 49. P. 990-993.Endoh C., Satoh M., Chin E. et al. Aberrations of the p53 gene in roentgenographically occult squamous cell carcinoma of the ung//Kyobu Geka. 1996. V. 49. P. 990-993.Murata M., Tagawa M., Kimura H. et al. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smokingrelated non-small cell lung cancer patients//Int. J. Oncol. 1998. V. 12 (3). P. 577-581.Murata M., Tagawa M., Kimura H. et al. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smokingrelated non-small cell lung cancer patients//Int. J. Oncol. 1998. V. 12 (3). P. 577-581.Huang X.E., Hamajima N., Katsuda N. et al. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer//Breast. Cancer. 2003. V. 10 (4). P. 307-311.Huang X.E., Hamajima N., Katsuda N. et al. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer//Breast. Cancer. 2003. V. 10 (4). P. 307-311.Bastiaens M.T., Struyk L., Tjong-A-Hung S.P. et al. Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening?//Mol. Carcinog. 2001. V. 30 (1). P. 56-61.Bastiaens M.T., Struyk L., Tjong-A-Hung S.P. et al. Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening?//Mol. Carcinog. 2001. V. 30 (1). P. 56-61.Lehman T.A., Haffty B.G., Carbone C.J. et al. Elevated Frequency and Functional Activity of a Specific Germ-Line p53 Intron Mutation in Familial Breast Cancer//Cancer Research. 2000. V. 60. P. 1062-1069.Lehman T.A., Haffty B.G., Carbone C.J. et al. Elevated Frequency and Functional Activity of a Specific Germ-Line p53 Intron Mutation in Familial Breast Cancer//Cancer Research. 2000. V. 60. P. 1062-1069.Lancaster J.M., Brownlee H.A., Wiseman R.W. et al. p53 polymorphism in ovarian and bladder cancer//Lancet. 1995. V. 346 (8968). P. 182.Lancaster J.M., Brownlee H.A., Wiseman R.W. et al. p53 polymorphism in ovarian and bladder cancer//Lancet. 1995. V. 346 (8968). P. 182.Campbell I.G., Eccles D.M., Dunn B. et al. p53 polymorphism in ovarian and breast cancer//Lancet. 1996. V. 347 (8998). P. 393-394.Campbell I.G., Eccles D.M., Dunn B. et al. p53 polymorphism in ovarian and breast cancer//Lancet. 1996. V. 347 (8998). P. 393-394.Mavridou D., Gornall R., Campbell I.G. et al. TP53 intron 6 polymorphism and the risk of ovarian and breast cancer//Br. J. Cancer. 1998. V. 77 (4). P. 676-677.Mavridou D., Gornall R., Campbell I.G. et al. TP53 intron 6 polymorphism and the risk of ovarian and breast cancer//Br. J. Cancer. 1998. V. 77 (4). P. 676-677.Gemignani F., Moreno V., Landi S. et al. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA//Oncogene. 2004. V. 23 (10). P. 1954-1956.Gemignani F., Moreno V., Landi S. et al. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA//Oncogene. 2004. V. 23 (10). P. 1954-1956.Mitra S., Sikdar N., Misra C. et al. Risk assessment of p53 genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern India//Int. J. Cancer. 2005. V. 117 (5). P. 786-793.Mitra S., Sikdar N., Misra C. et al. Risk assessment of p53 genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern India//Int. J. Cancer. 2005. V. 117 (5). P. 786-793.Tada M., Furuuchi K., Kaneda M. et al. Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants//Cancerogenesis. 2001. V. 22 (3). P. 515-517.Tada M., Furuuchi K., Kaneda M. et al. Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants//Cancerogenesis. 2001. V. 22 (3). P. 515-517.Сметанникова Н.А., Максимов В.Н., Устинов С.Н., Степанова Т.В., Завьялова Л.Г., Денисова Д.В., Шабалин А.В., Воевода М.И., Белявская В.А. Генотипы и гаплотипы гена-онкосупрессора р53: ассоциация с продолжительностью жизни у русских Новосибирской области//Сиб. онкол. журн. 2006. № 2. С. 37-41.Сметанникова Н.А., Максимов В.Н., Устинов С.Н., Степанова Т.В., Завьялова Л.Г., Денисова Д.В., Шабалин А.В., Воевода М.И., Белявская В.А. Генотипы и гаплотипы гена-онкосупрессора р53: ассоциация с продолжительностью жизни у русских Новосибирской области//Сиб. онкол. журн. 2006. № 2. С. 37-41.Sjilander A., Birgander R., Athlin L. et al. p53 germ-line haplotypes associated with increased risk for colorectal cancer//Carcinogenesis. 1995. V. 16. P. 1461-1464.Sjilander A., Birgander R., Athlin L. et al. p53 germ-line haplotypes associated with increased risk for colorectal cancer//Carcinogenesis. 1995. V. 16. P. 1461-1464.Hsieh L.L., Huang T.H., Chen I.H. et al. p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan//Br. J. Cancer. 2005. V. 92 (1). P. 30-35.Hsieh L.L., Huang T.H., Chen I.H. et al. p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan//Br. J. Cancer. 2005. V. 92 (1). P. 30-35.Mitra S., Misra C., Singh R.K. et al. Association of specific genotype and haplotype of p53 gene with cervical cancer in India//J. Clin. Pathol. 2005. V. 58 (1). P. 26-31.Mitra S., Misra C., Singh R.K. et al. Association of specific genotype and haplotype of p53 gene with cervical cancer in India//J. Clin. Pathol. 2005. V. 58 (1). P. 26-31.Khrunin A.V., Tarskaia L.A., Spitsyn V.A. et al. p53 polymorphisms in Russia and Belarus: correlation of the 2-1-1 haplotype frequency with longitude//Mol. Genet. Genomics. 2005. V. 272 (6). P. 666-672.Khrunin A.V., Tarskaia L.A., Spitsyn V.A. et al. p53 polymorphisms in Russia and Belarus: correlation of the 2-1-1 haplotype frequency with longitude//Mol. Genet. Genomics. 2005. V. 272 (6). P. 666-672.
The authors declare that there are no conflicts of interest present.